ADVFN
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,259.75
      -0.33%
      US Tech 100
      22,140.00
      -0.35%
      Dow Jones
      44,371.51
      -0.63%
      Brent Oil
      70.155
      0.00%
      Bitcoin
      117,684.91
      0.09%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Eli Lilly and Co (LLY) Quote

      Eli Lilly and Co

      Eli Lilly and Co (LLY)

      Lilly Eli and Co
      793.01
      2.36
      (0.30%)
      Closed July 12 4:00PM
      15 min delayed - Upgrade to Realtime
      791.86
      -1.15
      (-0.15%)
      After Hours: 7:59PM
      15 min delayed - Upgrade to Realtime

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      791.86
      ( 0.15% )
      Bid
      -
      Ask
      -
      Volume
      2,852,547
      777.20 Day's Range 795.73
      677.0912 52 Week Range 972.53
      Market Cap
      750.474B
      Previous Close
      790.65
      Open
      787.00
      Last Trade
      10
      @
      792
      Last Trade Time
      Financial Volume
      $ 2,238,763,093
      VWAP
      784.8295
      Average Volume (3m)
      3,838,987
      Shares Outstanding
      947,735,651
      Dividend Yield
      0.76%
      PE Ratio
      70.97
      Earnings Per Share (EPS)
      11.17
      Revenue
      45.04B
      Net Profit
      10.59B

      About Eli Lilly and Co

      Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.lilly.com
      Headquarters
      Indianapolis, Indiana, USA
      Founded
      -
      Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker LLY. The last closing price for Eli Lilly was $790.65. Over the last year, Eli Lilly shares have traded in a share price range of $ 677.0912 to $ 972.53.

      Eli Lilly currently has 947,735,651 shares outstanding. The market capitalization of Eli Lilly is $749.33 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 70.97.

      Ask ADVFN Intelligence (AI)

      Eli Lilly (LLY) Options Flow Summary

      LLY Options Flow

      Overall Flow

      Bullish

      Net Premium

      60M

      Calls / Puts

      230.70%

      Buys / Sells

      114.88%

      OTM / ITM

      140.13%

      Sweeps Ratio

      3.18%

      LLY Latest News

      More News

      Form SC TO-T - Tender offer statement by Third Party
      Edgar (US Regulatory)
      June 25 2025
      LLY (0.30%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 17 2025
      LLY (0.30%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      112.391.58954161161779.47799.4922762.032927113782.2170594CS
      4-18.43-2.27449431685810.29825755.563053054782.90979702CS
      12-52.64-6.2332741267844.5902.49997093838987777.58663779CS
      26-1.14-0.143757881463793935.625677.09123854802799.89193037CS
      52-143.14-15.3090909091935972.53677.09123636268820.33944917CS
      156461.18139.464134511330.68972.53296.323183730628.28116999CS
      260627.36381.373860182164.5972.53129.213235880458.50474298CS

      LLY - Frequently Asked Questions (FAQ)

      What is the current Eli Lilly share price?
      The current share price of Eli Lilly is $ 791.86
      How many Eli Lilly shares are in issue?
      Eli Lilly has 947,735,651 shares in issue
      What is the market cap of Eli Lilly?
      The market capitalisation of Eli Lilly is USD 749.33B
      What is the 1 year trading range for Eli Lilly share price?
      Eli Lilly has traded in the range of $ 677.0912 to $ 972.53 during the past year
      What is the PE ratio of Eli Lilly?
      The price to earnings ratio of Eli Lilly is 70.97
      What is the cash to sales ratio of Eli Lilly?
      The cash to sales ratio of Eli Lilly is 16.69
      What is the reporting currency for Eli Lilly?
      Eli Lilly reports financial results in USD
      What is the latest annual turnover for Eli Lilly?
      The latest annual turnover of Eli Lilly is USD 45.04B
      What is the latest annual profit for Eli Lilly?
      The latest annual profit of Eli Lilly is USD 10.59B
      What is the registered address of Eli Lilly?
      The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
      What is the Eli Lilly website address?
      The website address for Eli Lilly is www.lilly.com
      Which industry sector does Eli Lilly operate in?
      Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ZEPPZepp Health Corporation
      $ 10.32
      (69.46%)
      		3.06M
      FEDUFour Seasons Education Cayman Inc
      $ 16.00
      (35.59%)
      		12.31k
      STGSunlands Technology Group
      $ 9.10
      (21.98%)
      		88.73k
      SRFMSurf Air Mobility Inc
      $ 8.83
      (16.49%)
      		22.87M
      SQNSSequans Communications SA
      $ 4.515
      (15.77%)
      		20.25M
      BTCMBit Mining Limited
      $ 3.96
      (-36.64%)
      		7.03M
      WOLFWolfspeed Inc
      $ 1.335
      (-16.04%)
      		69.77M
      MEIMethode Electronics Inc
      $ 6.9309
      (-9.99%)
      		1.35M
      AGMFederal Agricultural Mortgage Corporation
      $ 177.20
      (-9.81%)
      		248.23k
      STEMStem Inc
      $ 8.41
      (-9.76%)
      		293.61k
      NIONIO Inc
      $ 3.91
      (5.96%)
      		141.54M
      BBAIBigBear ai Holdings Inc
      $ 6.435
      (-9.62%)
      		129.71M
      WOLFWolfspeed Inc
      $ 1.335
      (-16.04%)
      		69.77M
      FFord Motor Company
      $ 11.76
      (-1.26%)
      		65.34M
      NUNu Holdings Ltd
      $ 12.84
      (-1.46%)
      		63.89M

      LLY Discussion

      View Posts
      Saving Grace Saving Grace 4 days ago
      Wow! Elite are really pumping this pig.Not for log
      👍️0
      BottomBounce BottomBounce 2 months ago
      First, @P_McCulloughMD who is one of the most published people in the world on Covid vaccine myocarditis spoke.

      He saw warning signs as early as August of 2021 that the vaccines can cause myocarditis… pic.twitter.com/Gexd9yXOhU— Anna Matson (@AnnaRMatson) May 22, 2025 $LLY
      👍️0
      BottomBounce BottomBounce 2 months ago
      $LLY "This is not a vaccine... It's a genetic experiment at best. And that's without even talking about all the nanotech, just... the biological elements...this is Frankenstein science... [and before COVID] less than 400 humans were ever experimented with with MRNA."

      Dr. Mark Trozzi… pic.twitter.com/eBB4NOa3I8— Sense Receptor (@SenseReceptor) May 14, 2025 LLY
      👍️0
      TechandBio TechandBio 2 months ago
      GSK pays 2 Billion for Boston Pharma a IV LLY should scoop up SGMT the oral with the breakthrough designation.

      MDGL just partnered with SGMT combining one oral tablet makes MDGL THR Beta work 80% compared to 25% alone Plus works incredibly well with GLP1 data with semaglutide & SGMT oral enhanced efficacy tremendously with SGMT Fatty synthesis the only one in the clinic world wide. SGMT has breakthrough designation for their phase 3 ready Mash Trials and Pediatric Mash the only in the clinic phase 2 Ready for Pediatric


      $LLY
      👍️0
      Saving Grace Saving Grace 2 months ago
      The pump before the dump! Look out below. Super cave Tuesday coming.
      👍️0
      BottomBounce BottomBounce 2 months ago
      So many children are getting cancer, yet, no one wants to consider vaccines as the culprit.

      This needs to change. @RobertKennedyJr @POTUS pic.twitter.com/ZvK4IgS2T5— Died Suddenly (@DiedSuddenly_) May 10, 2025 $LLY
      👍️0
      BottomBounce BottomBounce 2 months ago
      $LLY Total Debt (mrq) $34.91B
      👍️0
      Monksdream Monksdream 2 months ago
      LLY, 10Q due 5/1
      👍️0
      makinezmoney makinezmoney 3 months ago
      $LLY: Those 4/17 $800calls ..... PURE GENIUS.... up 535,900%

      JUST ON THE DAY !!!!!!!!!!!!!


      You wanna hit the LOTTERY on the OPTIONS MARKET................ THATs HOW YOU EFFIN DO !!!!!!!!!

      This has to be the biggest INTRADAY Options YIELD I have EVER SEEN.

      I don't think the days of seeing a 1Million% yield are far off now............ That is going to make someone AN INSTANT BILLIONAIRE !!!!!

      I can't believe more people aren't talking about this here.

      Completely MIND BLOWING.... everyone out there pumping their PENNY STOCKS while this is how you make that EZ MONEY baby.


      These wkly $800 calls were only $0.01 yesterday............. right now they are at $53.60 !!!!!!!!!!!!

      0dte calls are HYPERACTIVE MONEY MAKERS if you know you're crap and there were clearly some loaders on this YESTERDAY as you can see the volume activity on this chart.

      This news came out at 6am EST today but you can see from yesterdays activity, there
      were insiders and their friends that were clearly ahead of the game and were already positioning
      themselves in on these.

      https://www.prnewswire.com/news-releases/lillys-oral-glp-1-orforglipron-demonstrated-statistically-significant-efficacy-results-and-a-safety-profile-consistent-with-injectable-glp-1-medicines-in-successful-phase-3-trial-302430985.html



      GO $LLY
      👍 2
      double_m double_m 3 months ago
      And who says buying the dip was a bad idea. I love this stock!!! 🚀
      👍️0
      makinezmoney makinezmoney 3 months ago
      $LLY: Amazing 560k % YIELD on those $800wkly calls !!!!!!!!!!!!!!




      GO $LLY
      👍️0
      BottomBounce BottomBounce 3 months ago
      $LLY Total Debt (mrq) $34.91B Pump and Dump Scam stock https://www.cnbc.com/2025/03/31/vaccine-stocks-fall-after-fdas-peter-marks-resigns-over-rfk-jr.html
      👍️0
      TechandBio TechandBio 4 months ago
      Back in option play up 24% in a week for July

      $LLY
      👍️0
      BottomBounce BottomBounce 6 months ago
      Eli Lilly and Company $LLY Total Debt (mrq) $31.23B Massive debt compared to dwinding cash. Pump and dump
      👍️0
      peanutz peanutz 6 months ago
      Another gloom and doomer . Lilly is fine . I worked there over 10 years and they have a ton in the pipeline . It needs a breather . Crash my a$$
      👍️0
      MartinLutherKing MartinLutherKing 6 months ago
      RNAZ micro rna cancer cure ELAB el-22 obesity target buyout in progress
      👍️ 1
      MomsSpaghetti MomsSpaghetti 7 months ago
      Are you saying small biotech has a chance...? I was thinking the other way...

      Eli Lilly has been a major player in CNS disorders, particularly with treatments for depression (e.g., Prozac) and schizophrenia. They are actively exploring new areas in psychiatry, including the potential for psychedelics.

      Lilly has shown interest in novel treatments for depression and anxiety and has partnered with companies in the psychedelic space. Their expansion into the psychedelic field could be an opportunity to leverage MindMed's expertise in developing treatments using substances like LSD and MDMA.

      I am wondering if they (or others) would might possibly acquire them.
      👍️0
      fung_derf fung_derf 7 months ago
      I've been waiting and waiting for this one to pull back and it has. However, it is fighting mightily to hold support here....Right now I'm thinking it looks moderately hopeful here, but I think $NVO has become the better play now.
      👍️0
      Saving Grace Saving Grace 8 months ago
      Industry changing direction. Big Pharma going south! LLY a major short candidate going into 2025.
      👍️0
      TechandBio TechandBio 9 months ago
      $1000 strikes for Jan 2025 look juicy.

      $LLY
      👍️0
      uksausage uksausage 9 months ago
      why?
      👍️0
      Saving Grace Saving Grace 9 months ago
      Big Pharma to crash hard. Be prepared!
      👍️0
      TechandBio TechandBio 10 months ago
      Wonder if Lily Buys SMMT.
      $LLY
      👍️0
      DewDiligence DewDiligence 10 months ago
      LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):

      https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials… — at a far lower price than its pens, which come with pre-filled doses. These vials will be made available only through LillyDirect, a telehealth platform the company launched in January (https://investor.lilly.com/news-releases/news-release-details/lilly-launches-end-end-digital-healthcare-experience-through ).

      …The vials are significantly cheaper than Zepbound pens, which cost just over $1,000 a month without insurance. A month’s supply of the 2.5-milligram dose will cost $399, and a month’s worth of the five-milligram dose will cost $549.

      … The company will offer vials with only the two lowest doses of Zepbound. Many patients stay on a five milligram dose… but some gradually increase their dose, up to a maximum of 15 milligrams. Any patient interested in taking more than the five-milligram dose would have to transition to the pens.

      …the move could help Lilly regain customers who are currently getting compounded tirzepatide, which typically costs between roughly $250 and $450 a month. Why would anyone want a compounded formulation of tirzepatide derived from Chinese API when they can get the real thing from LLY at close to the same price?
      👍️0
      Monksdream Monksdream 11 months ago
      LLY new 52=week high
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      To quote Areosmith ' I'm back in the saddle again' . 💰
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      In the green premarket again. 🍷
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      Bought back in at open today. 🍷
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      In regards to new a pharma product.
      👍️0
      Zardiw Zardiw 11 months ago
      $LLY Chart from #DDAmanda - #1 Stock Screener :



      Z
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      Added @ $866.29
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      Going to be another green day.
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      I don't think they have sales in Europe yet, that'll change. 💰💰💰
      👍️0
      EnchantedTitan62 EnchantedTitan62 11 months ago
      Uh, probably not .
      👍️0
      Monksdream Monksdream 12 months ago
      LLY new 52=week high
      👍️0
      EL Sueno EL Sueno 1 year ago
      Let's go fans 1000.00!!!
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      LLY 10Q due 4/30
      Next day setttlement begins 5/28
      👍️0
      north40000 north40000 1 year ago
      FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
      👍️0
      Alfonz66 Alfonz66 1 year ago
      Sell now boys you had a great run
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52 week high

      👍️0
      oldstocks oldstocks 1 year ago
      Eli Lilly was investigating Talampanel prior to 2010

      For the treatment of epilepsy, malignant gliomas and ALS
      development codes LY-300164 , LY300164
      results from the trial for ALS have been found negative
      Talampanel is not currently under development.
      It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
      RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
      Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
      👍️0
      ralphey ralphey 1 year ago
      I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
      👍️0
      Monksdream Monksdream 1 year ago
      Incredible, isn’t it
      What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
      Because they are incapable of researching companies
      🌈 1 🍆 1
      vinsterr vinsterr 1 year ago
      800$ tomorrow?
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52=week high
      👍️0
      Monksdream Monksdream 1 year ago
      LLY new 52 week high
      👍️0

      Your Recent History

      NYSE
      LLY
      Eli Lilly
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads